Literature DB >> 8973585

The cytotoxic activity of Bacillus anthracis lethal factor is inhibited by leukotriene A4 hydrolase and metallopeptidase inhibitors.

A Menard1, E Papini, M Mock, C Montecucco.   

Abstract

The lethal factor of Bacillus anthracis is central to the pathogenesis of anthrax. Its mechanism of action is still unknown. Recently, on the basis of sequence similarities, we suggested that lethal factor might act similarly to leukotriene A4 hydrolase (LTA4), a bifunctional enzyme also endowed with a metallopeptidase activity. Here we show that some inhibitors of the LTA4 hydrolase and metallopeptidase activities of LTA4 hydrolase also affect the cytotoxicity of the anthrax lethal factor on macrophage cell lines, without interfering with the ability of the lethal factor to enter cells. These results support the proposal that anthrax lethal factor might display in the cytosol of intoxicated cells a peptidase activity similar to that of LTA4 hydrolase.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8973585      PMCID: PMC1217984          DOI: 10.1042/bj3200687

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  30 in total

1.  MK886, a potent and specific leukotriene biosynthesis inhibitor blocks and reverses the membrane association of 5-lipoxygenase in ionophore-challenged leukocytes.

Authors:  C A Rouzer; A W Ford-Hutchinson; H E Morton; J W Gillard
Journal:  J Biol Chem       Date:  1990-01-25       Impact factor: 5.157

Review 2.  Enzymes involved in the biosynthesis of leukotriene B4.

Authors:  B Samuelsson; C D Funk
Journal:  J Biol Chem       Date:  1989-11-25       Impact factor: 5.157

3.  Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill.

Authors:  M B Hansen; S E Nielsen; K Berg
Journal:  J Immunol Methods       Date:  1989-05-12       Impact factor: 2.303

4.  Inhibition of leukotriene synthesis markedly accelerates healing in a rat model of inflammatory bowel disease.

Authors:  J L Wallace; W K MacNaughton; G P Morris; P L Beck
Journal:  Gastroenterology       Date:  1989-01       Impact factor: 22.682

5.  L-663,536 (MK-886) (3-[1-(4-chlorobenzyl)-3-t-butyl-thio-5-isopropylindol-2-yl]-2,2 - dimethylpropanoic acid), a novel, orally active leukotriene biosynthesis inhibitor.

Authors:  J Gillard; A W Ford-Hutchinson; C Chan; S Charleson; D Denis; A Foster; R Fortin; S Leger; C S McFarlane; H Morton
Journal:  Can J Physiol Pharmacol       Date:  1989-05       Impact factor: 2.273

6.  Leukotriene A4 hydrolase. Inhibition by bestatin and intrinsic aminopeptidase activity establish its functional resemblance to metallohydrolase enzymes.

Authors:  L Orning; G Krivi; F A Fitzpatrick
Journal:  J Biol Chem       Date:  1991-01-25       Impact factor: 5.157

7.  Leukotriene A4 hydrolase: determination of the three zinc-binding ligands by site-directed mutagenesis and zinc analysis.

Authors:  J F Medina; A Wetterholm; O Rådmark; R Shapiro; J Z Haeggström; B L Vallee; B Samuelsson
Journal:  Proc Natl Acad Sci U S A       Date:  1991-09-01       Impact factor: 11.205

8.  Inhibition of leukotriene A4 hydrolase/aminopeptidase by captopril.

Authors:  L Orning; G Krivi; G Bild; J Gierse; S Aykent; F A Fitzpatrick
Journal:  J Biol Chem       Date:  1991-09-05       Impact factor: 5.157

9.  Pharmacological properties of acetorphan, a parenterally active "enkephalinase" inhibitor.

Authors:  J M Lecomte; J Costentin; A Vlaiculescu; P Chaillet; H Marcais-Collado; C Llorens-Cortes; M Leboyer; J C Schwartz
Journal:  J Pharmacol Exp Ther       Date:  1986-06       Impact factor: 4.030

10.  Requirement of a 5-lipoxygenase-activating protein for leukotriene synthesis.

Authors:  R A Dixon; R E Diehl; E Opas; E Rands; P J Vickers; J F Evans; J W Gillard; D K Miller
Journal:  Nature       Date:  1990-01-18       Impact factor: 49.962

View more
  6 in total

1.  Susceptibility of mitogen-activated protein kinase kinase family members to proteolysis by anthrax lethal factor.

Authors:  G Vitale; L Bernardi; G Napolitani; M Mock; C Montecucco
Journal:  Biochem J       Date:  2000-12-15       Impact factor: 3.857

2.  Proteasome activity is required for anthrax lethal toxin to kill macrophages.

Authors:  G Tang; S H Leppla
Journal:  Infect Immun       Date:  1999-06       Impact factor: 3.441

Review 3.  Binary bacterial toxins: biochemistry, biology, and applications of common Clostridium and Bacillus proteins.

Authors:  Holger Barth; Klaus Aktories; Michel R Popoff; Bradley G Stiles
Journal:  Microbiol Mol Biol Rev       Date:  2004-09       Impact factor: 11.056

4.  High-affinity, human antibody-like antibody fragment (single-chain variable fragment) neutralizing the lethal factor (LF) of Bacillus anthracis by inhibiting protective antigen-LF complex formation.

Authors:  Thibaut Pelat; Michael Hust; Emmanuelle Laffly; Florence Condemine; Chantal Bottex; Dominique Vidal; Marie-Paule Lefranc; Stefan Dübel; Philippe Thullier
Journal:  Antimicrob Agents Chemother       Date:  2007-05-21       Impact factor: 5.191

5.  Designed azolopyridinium salts block protective antigen pores in vitro and protect cells from anthrax toxin.

Authors:  Christoph Beitzinger; Anika Bronnhuber; Kerstin Duscha; Zsuzsanna Riedl; Markus Huber-Lang; Roland Benz; György Hajós; Holger Barth
Journal:  PLoS One       Date:  2013-06-20       Impact factor: 3.240

6.  Profiling lethal factor interacting proteins from human stomach using T7 phage display screening.

Authors:  Albin Cardona-Correa; Carlos Rios-Velazquez
Journal:  Mol Med Rep       Date:  2016-03-21       Impact factor: 2.952

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.